Collectively our findings suggest that GPR141 regulates breast tumorigenesis via modulating p-mTOR1/p53 signaling, EMT biomarkers, oncogenes expression, and the tumor microenvironment in vitro and in vivo, as an annotated simulation model in detail (Figure 7). The gene discussed is TP53; the disease is neoplasm.